Addex Therapeutics Statistics
Total Valuation
SWX:ADXN has a market cap or net worth of CHF 5.88 million. The enterprise value is 3.10 million.
Market Cap | 5.88M |
Enterprise Value | 3.10M |
Important Dates
The last earnings date was Thursday, June 19, 2025.
Earnings Date | Jun 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SWX:ADXN has 98.35 million shares outstanding. The number of shares has increased by 17.91% in one year.
Current Share Class | 98.35M |
Shares Outstanding | 98.35M |
Shares Change (YoY) | +17.91% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 26.71% |
Owned by Institutions (%) | 4.22% |
Float | 26.11M |
Valuation Ratios
The trailing PE ratio is 0.68.
PE Ratio | 0.68 |
Forward PE | n/a |
PS Ratio | 23.89 |
PB Ratio | 0.71 |
P/TBV Ratio | 0.71 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.36 |
EV / Sales | 12.58 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.82 |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.00.
Current Ratio | 3.03 |
Quick Ratio | 2.71 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | -0.01 |
Interest Coverage | -738.63 |
Financial Efficiency
Return on equity (ROE) is -163.15% and return on invested capital (ROIC) is -45.97%.
Return on Equity (ROE) | -163.15% |
Return on Assets (ROA) | -25.09% |
Return on Invested Capital (ROIC) | -45.97% |
Return on Capital Employed (ROCE) | -30.53% |
Revenue Per Employee | 123,094 |
Profits Per Employee | 4.34M |
Employee Count | 2 |
Asset Turnover | 0.04 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.69% in the last 52 weeks. The beta is 1.99, so SWX:ADXN's price volatility has been higher than the market average.
Beta (5Y) | 1.99 |
52-Week Price Change | +0.69% |
50-Day Moving Average | 0.06 |
200-Day Moving Average | 0.06 |
Relative Strength Index (RSI) | 53.03 |
Average Volume (20 Days) | 304,902 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:ADXN had revenue of CHF 246,187 and earned 8.67 million in profits. Earnings per share was 0.09.
Revenue | 246,187 |
Gross Profit | -519,059 |
Operating Income | -2.57M |
Pretax Income | -5.65M |
Net Income | 8.67M |
EBITDA | -2.38M |
EBIT | -2.57M |
Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 2.83 million in cash and 40,202 in debt, giving a net cash position of 2.79 million or 0.03 per share.
Cash & Cash Equivalents | 2.83M |
Total Debt | 40,202 |
Net Cash | 2.79M |
Net Cash Per Share | 0.03 |
Equity (Book Value) | 8.30M |
Book Value Per Share | 0.08 |
Working Capital | 2.14M |
Cash Flow
In the last 12 months, operating cash flow was -3.78 million and capital expenditures -1,273, giving a free cash flow of -3.78 million.
Operating Cash Flow | -3.78M |
Capital Expenditures | -1,273 |
Free Cash Flow | -3.78M |
FCF Per Share | -0.04 |
Margins
Gross margin is -210.84%, with operating and profit margins of -1,045.30% and 3,521.74%.
Gross Margin | -210.84% |
Operating Margin | -1,045.30% |
Pretax Margin | -2,293.80% |
Profit Margin | 3,521.74% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SWX:ADXN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.91% |
Shareholder Yield | n/a |
Earnings Yield | 147.42% |
FCF Yield | -64.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SWX:ADXN has an Altman Z-Score of -49.11 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -49.11 |
Piotroski F-Score | 2 |